MIRA
INFORM REPORT
|
Report Date : |
31.01.2014 |
IDENTIFICATION DETAILS
|
Name : |
RELIANCE LIFE
SCIENCES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane
Belapur Road, Rabale, Navi Mumbai – 400 701, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
30.01.2001 |
|
|
|
|
Com. Reg. No.: |
11-130654 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.293.850 Millions |
|
|
|
|
CIN No.: [Company Identification No.] |
U24239MH2001PTC130654 |
|
|
|
|
TIN No.: |
27830130587 |
|
|
|
|
TAN No.: [Tax Deduction & Collection Account No.] |
MUMR10629D |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AABCR7594L |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of
Business : |
Subject is involved
in domains such as biopharmaceuticals (plasma proteins, bio-similars, novel
proteins), pharmaceuticals (active pharmaceutical intermediates (APIs),
formulations, drug discovery), clinical research services, regenerative
medicine (stem cell therapies, tissue engineered products, etc.), molecular
medicine (DNA-based diagnostics, molecular genetics, predictive diagnostics),
novel therapeutics (RNA molecules), R & D activities, plant tissue
culture, plant metabolic engineering and industrial biotechnology
(biopolymers, bio-chemicals). |
|
|
|
|
No. of Employees
: |
1000 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
A (62) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 4400000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a part of Reliance Group. It is a well-established and
reputed company having fine track record. The external borrowing seems to be huge. However, the company gets good financial and managerial support from
its parent company. Financial position of the company seems to be sound. Directors are reported to be experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are
reported to be regular and as per commitments. In view of strong, the company can be considered good for business
dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 1, 2013
|
Country Name |
Previous Rating (30.09.2013) |
Current Rating (01.12.2013) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
The services sector, the largest contributor to India’s GDP, contracted
for the sixth consecutive month in December, as orders dipped. However, hiring
has risen. Direct tax collections rose 12.3 % during the April – December
period of the current financial year. The government has decided to
retain 100 per cent foreign direct investment in both greenfield (new) and
brown field (existing) pharmaceutical companies, despite concerns over genetic
drugs going out of production, if multi-national companies take over domestic
ones. In M&A deals, a non compete clause would not be allowed, except in
special circumstances. The Department of Industrial Policy and Promotion plans
to release the next edition of its consolidated foreign direct investment
policy document on March 31, incorporating changes made in the past year. DIPP
compiles all policies related to India’s FDI regime into a single document to
make it easy for investors to understand. 185 million estimated number of
mobile internet users in India by June 2014, according to a report by the
Internet & Mobile Association of India and IMRB International. India
had 110 million mobile internet users with 25 million in rural areas. $3.77 tn
estimated global IT spending in 2014, according to research firm Gartner Inc.
The growth forecast for this year is cut to 3.1 %from the earlier estimate of
3.5 %. The spending growth forecast for telecom services – a segment that
accounts for more than 40 % at total IT spending – from 1.9 per cent to 1.2 per
cent is the main reason for this overall IT cut. A Reserve Bank of India
committee has recommended setting up a special category of lenders who would
cater to small businesses and households, to expand the number of customers
with access to banking services. These banks would focus onproviding payment
services and deposit products. Indian banks want the free use of
automated teller machines to be capped at five transactions in a month
including that of the bank in which the account is active. This follows state
government order to banks to install security guards at ATM booths after a
woman banker was assaulted in Bangalore. The government is likely to present a
vote on Account in mid-February. The annual Economic Survey will be tabled
later in Parliament along with the full Budget. A full Budget for 2014/15 is
likely to be present in July by the new government formed after the General
Election. The government will soon launch an internet spy system, called Netra,
to detect malafide messages. Security agency will deploy the system to capture
dubious voice traffic on applications such as Skype and Google Talk, as well as
tweeters.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CARE |
|
Rating |
AA
(Long Term Bank Facilities ) |
|
Rating Explanation |
High degree of safety and very low credit
risk |
|
Date |
December 02, 2013 |
|
Rating Agency Name |
CARE |
|
Rating |
A1+ (Short Term Bank Facilities) |
|
Rating Explanation |
Very strong degree of safety and lowest
credit risk |
|
Date |
December 02, 2013 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
LOCATIONS
|
Registered Office : |
Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane Belapur
Road, Rabale, Navi Mumbai – 400 701, Maharashtra, India |
|
Tel. No.: |
91-22-67678000/
39118000 |
|
Fax No.: |
91-22-67678099/
39118099 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate
Office : |
3rd Floor Sadhana House, Behind Mahindra Towers, 570, Pandurang Bhudkar Marg Worli, Mumbai – 400 018, Maharashtra, India
|
|
|
|
|
Factory : |
1st Floor, Sadhana Mills Premises, 570,
Pandurang Budhkar Marg, Mumbai - 400 018, Maharashtra, India |
|
|
|
|
Branch Office
: |
Located
at:
|
DIRECTORS
AS ON 30.09.2013
|
Name : |
Mr. Rahul Ramesh Padhye |
|
Designation : |
Whole Time Director |
|
Address : |
Flat No. 31, 3rd Floor, A Wing, Indrayani Complex, J.K. Sawant
Marg, Dadar (West), Mumbai – 400028, Maharashtra, India |
|
Date of Birth/Age : |
29.06.1972 |
|
Date of Appointment : |
30.09.2013 |
|
DIN No.: |
01555700 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U85195MH2007PTC168878 |
RELIANCE
BIOPHARMACEUTICALS PRIVATE LIMITED |
Director |
12/09/2008 |
12/06/2007 |
- |
Amalgamated |
NO |
|
2 |
U24239MH2001PTC130654 |
RELIANCE LIFE
SCIENCES PRIVATE LIMITED |
Whole-time
director |
30/09/2013 |
18/06/2013 |
- |
Active |
NO |
|
Name : |
Mr. Laxmidas Vallabhdas Merchant |
|
Designation : |
Director |
|
Address : |
Ramkrupa Tower, 9th Floor Block Nbo 12, Dr. Parekh Street,
Prathana Samaj, Mumbai – 400 004, Maharashtra, India |
|
Date of Birth/Age : |
14.11.1959 |
|
Qualification : |
B. Com., Chartered Accountant |
|
Date of Appointment : |
29.09.2007 |
|
DIN No.: |
00007722 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U51900PN1992PTC141422 |
VELOCIPED
TRADING PRIVATE LIMITED |
Director |
21/01/1992 |
21/01/1992 |
18/02/2013 |
Active |
NO |
|
2 |
U51900MH1965PTC014453 |
RELIANCE EXPORTS
PRIVATE LIMITED |
Director |
02/09/1993 |
02/09/1993 |
02/06/2009 |
Active |
NO |
|
3 |
U74140MH1995PLC087756 |
RELIANCE GLOBAL
MANAGEMENT SERVICES LIMITED |
Director |
10/05/1999 |
10/05/1999 |
- |
Amalgamated |
NO |
|
4 |
U24120MH1999PLC121009 |
RELIANCE
VENTURES LIMITED |
Director |
05/10/1999 |
05/10/1999 |
- |
Active |
NO |
|
5 |
U65990MH1999PLC120918 |
RELIANCE
STRATEGIC INVESTMENTS LIMITED |
Director |
01/12/1999 |
01/12/1999 |
- |
Active |
NO |
|
6 |
U51900MH2000PTC125501 |
ANTILIA
COMMERCIAL PRIVATE LIMITED |
Director |
22/03/2004 |
22/03/2004 |
29/12/2012 |
Active |
NO |
|
7 |
U72200MH2005PTC154456 |
RELIANCE
INFOSOLUTIONS PRIVATE LIMITED |
Director |
30/09/2006 |
12/04/2006 |
- |
Amalgamated |
NO |
|
8 |
U74999MH2007PTC167376 |
Dhanishta
Commercials Private Limited |
Director |
25/09/2007 |
22/03/2007 |
- |
Active |
NO |
|
9 |
U24239MH2001PTC130654 |
RELIANCE LIFE
SCIENCES PRIVATE LIMITED |
Director |
29/09/2007 |
01/06/2007 |
- |
Active |
NO |
|
10 |
L99999MH1961PLC012185 |
BALKRISHNA
INDUSTRIES LIMITED |
Director |
22/01/2009 |
22/01/2009 |
- |
Active |
NO |
|
11 |
U64202MH2005PTC150752 |
CONVONIX SYSTEMS
PRIVATE LIMITED |
Director |
30/09/2009 |
27/01/2009 |
06/03/2013 |
Active |
NO |
|
12 |
U74900MH2007PTC171234 |
VANISHREE
COMMERCIALS PRIVATE LIMITED |
Director |
26/09/2011 |
31/01/2011 |
- |
Active |
NO |
|
Name : |
Mr. Dinesh Bhaskar Sathe |
|
Designation : |
Whole Time Director |
|
Address : |
A2-601, Rutu Park CHS., RW Sawant Marg, Majiwada, Thane – 400 601,
Maharashtra, India |
|
Date of Birth/Age : |
04.10.1956 |
|
Qualification : |
B.E.(MECH), DMS |
|
Date of Appointment : |
30.09.2010 |
|
PAN No.: |
AERPS8523B |
|
DIN No.: |
02876683 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24239MH2001PTC130654 |
RELIANCE LIFE
SCIENCES PRIVATE LIMITED |
Whole-time
director |
30/09/2010 |
11/12/2009 |
- |
Active |
NO |
KEY EXECUTIVES
|
Name : |
Mr. Hardeep Singh Sodhi |
|
Designation : |
Secretary |
|
Address : |
D – 1/8 – 6, Millenium Towers, Sector – 9, Sanpada, Navi Mumbai –
400705, Maharashtra, India |
|
Date of Birth/Age : |
14.08.1966 |
|
Date of Appointment : |
01.02.2013 |
|
PAN No.: |
ABHPS7806G |
|
|
|
|
Name : |
Dr. Vishwanath
B. Malkar |
|
Designation : |
Head–Regulatory |
|
|
|
|
Name : |
Mr. Rajesh C.
Hedaoo |
|
Designation : |
Head API
Projects & Kil |
|
|
|
|
Name : |
Mr. Vikram
Paradkar |
|
Designation : |
Head – Process
Development |
MAJOR SHAREHOLDERS
AS ON 30.09.2013
|
Names of Shareholders (Equity Shares) |
No. of Shares |
|
Reliance Health
and Technology Private Limited, India |
1700 |
|
Healthcare
Systems and Solution Global Private Limited, India |
1600 |
|
Reliance Agrotech
Private Limited, India |
1000 |
|
Ekansha Enterprise Private Limited, India |
1700 |
|
Reliance Research and Development Services Private Limited, Mumbai |
1700 |
|
Reliance Qualnet.com Private Limited, Mumbai |
1300 |
|
Reliance Web Spiders.com Private Limited, Mumbai |
1000 |
|
Total
|
10000 |
|
Names of Shareholders (9% Optionally Convertible Non-cumulative
Redeemable Preference Shares) |
No. of Shares |
|
Reliance Ports
and Terminals Limited, India |
8125000 |
|
Total
|
8125000 |
|
Names of Shareholders (10% Non-Convertible Non-cumulative Redeemable
Preference Shares : Series - II) |
No. of Shares |
|
Reliance Ports
and Terminals Limited, India |
1500000 |
|
Total
|
1500000 |
|
Names of Shareholders (9% Optionally Convertible Non-cumulative
Redeemable |
No. of Shares |
|
Reliance Ports
and Terminals Limited, India |
19750000 |
|
Total
|
19750000 |
AS ON 30.09.2013
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Bodies
corporate |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is
involved in domains such as biopharmaceuticals (plasma proteins, bio-similars,
novel proteins), pharmaceuticals (active pharmaceutical intermediates (APIs),
formulations, drug discovery), clinical research services, regenerative
medicine (stem cell therapies, tissue engineered products, etc.), molecular
medicine (DNA-based diagnostics, molecular genetics, predictive diagnostics),
novel therapeutics (RNA molecules), R & D activities, plant tissue
culture, plant metabolic engineering and industrial biotechnology
(biopolymers, bio-chemicals). |
||||||||
|
|
|
||||||||
|
Products : |
|
PRODUCTION STATUS (AS ON 31.03.2011)
Licensed capacity,
installed capacity and actual production
Manufacturing
licenses for various products have been obtained from respective regulatory
authorities. The approvals do not specify any capacity. Installed capacities
are variable and subject to product mix and utilisation
of manufacturing facilities, given the nature of operations.
|
Particulars |
Unit |
Actual
Production |
|
Biopharmaceutical
Products: |
|
|
|
Vials |
Nos. |
926692 |
|
Kits |
Nos. |
8224 |
|
Syringe |
Nos. |
218782 |
|
Plant Products |
Nos. |
2964239 |
GENERAL INFORMATION
|
No. of Employees : |
1000 (Approximately) |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Bankers : |
·
Canara Bank, Prime Corporate Branch II, 2nd
Floor, Varma Chambers, Homji Street, Fort, Mumbai – 400 001, Maharashtra,
India |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Facilities : |
Loans From
Department of Biotechnology: (A)The secured loans
taken from Department of Biotechnology (DBT) is secured by hypothecation of
the whole of movable properties of the Company created under the respective
projects and acquired from the respective loan sanctioned by the DBT
including movable plant and machinery, machinery spares, tools and
accessories and other movables both present and future (save and except book
debts) for the said projects. Term Loans from
Department of Biotechnology (DBT) are payable in ten equal annual
installments and will commence after six months of the scheduled completion
of the project. (A) Secured
Working capital loan from bank is secured by hypothecation of stocks and book
debts of the Company. |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Chaturvedi and Shah Chartered Accountants |
|
Address : |
714-715, Tulsiani Chambers, Nariman Point, Mumbai – 400 021,
Maharashtra, India |
|
Tel. No.: |
91-22-56308508 |
|
PAN No.: |
AAAFC0662N |
|
|
|
|
Associates : |
·
Reliance Health and
Technology Private Limited CIN No.: U85199MH2000PTC126806 ·
Healthcare
Systems and Solutions Global Private Limited CIN No.: U85199MH2000PTC126387 ·
Reliance
Agrotech Private Limited CIN No.: U01110GJ1994PTC021440 ·
Reliance
Research & Development Services Private Limited CIN No.: U15300MH1999PTC123316 |
|
|
|
|
Subsidiaries : |
·
Reliance Life Sciences B.V., Netherland ·
Reliance Life Sciences Inc, USA ·
Reliance GeneMedix Limited, U.K. (formerly Reliance GeneMedix Plc) (a Subsidiary of Reliance Life Sciences
B.V.) ·
Genemedix Ireland Limited (a Subsidiary of Reliance GeneMedix
Limited) |
CAPITAL STRUCTURE
AS ON 30.09.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
510000 |
Equity Shares |
Rs.10/- each |
Rs.5.100 Millions |
|
29500000 |
Preference
Shares |
Rs.10/- each |
Rs.295.000
Millions |
|
|
Total
|
|
Rs.300.100
Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10000 |
Equity Shares |
Rs.10/- each |
Rs. 0.100 Million |
|
29375000 |
Preference
Shares |
Rs.10/- each |
Rs. 293.750
Millions |
|
|
Total
|
|
Rs.293.850
Millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders'
Funds |
|
|
|
|
(a) Share Capital |
293.850 |
96.350 |
96.350 |
|
(b) Reserves & Surplus |
786.099 |
613.993 |
698.122 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2)
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
1079.949 |
710.343 |
794.472 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
5540.822 |
5597.922 |
5546.278 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long term liabilities |
3.466 |
0.368 |
0.000 |
|
(d) long-term provisions |
0.000 |
0.000 |
0.000 |
|
Total Non-current Liabilities (3) |
5544.288 |
5598.290 |
5546.278 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
806.059 |
897.987 |
541.502 |
|
(b) Trade
payables |
1036.444 |
661.110 |
672.843 |
|
(c) Other
current liabilities |
187.383 |
192.043 |
303.220 |
|
(d) Short-term provisions |
38.163 |
20.442 |
42.824 |
|
Total Current
Liabilities (4) |
2068.049 |
1771.582 |
1560.389 |
|
|
|
|
|
|
TOTAL |
8692.286 |
8080.215 |
7901.139 |
|
|
|
|
|
|
I.
ASSETS |
|
|
|
|
(1) Non-current
assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
2444.656 |
2184.239 |
2036.182 |
|
(ii)
Intangible Assets |
142.277 |
228.409 |
70.732 |
|
(iii)
Capital work-in-progress |
144.410 |
434.310 |
582.235 |
|
(iv) Intangible assets under
development |
188.795 |
98.233 |
140.552 |
|
(b) Non-current Investments |
2181.905 |
2181.905 |
2181.186 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
1102.630 |
952.281 |
712.860 |
|
(e) Other Non-current assets |
172.613 |
104.679 |
48.642 |
|
Total Non-Current
Assets |
6377.286 |
6184.056 |
5772.389 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
1272.009 |
737.521 |
758.767 |
|
(c) Trade
receivables |
743.150 |
814.958 |
987.991 |
|
(d) Cash
and cash equivalents |
44.151 |
50.296 |
49.735 |
|
(e)
Short-term loans and advances |
255.690 |
292.719 |
332.257 |
|
(f) Other current
assets |
0.000 |
0.665 |
0.000 |
|
Total Current Assets |
2315.000 |
1896.159 |
2128.750 |
|
|
|
|
|
|
TOTAL |
8692.286 |
8080.215 |
7901.139 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
SALES |
|
|
|
|
|
|
|
|
4334.700 |
|
|
|
|
|
Other Income |
|
|
|
|
|
|
TOTAL (A) |
4334.700 |
3338.100 |
2840.000 |
|
|
|
|
|
|
|
|
Less |
TOTAL
EXPENSES
(B) |
3928.137 |
3145.098 |
2694.992 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
406.563 |
193.002 |
145.008 |
|
|
|
|
|
|
|
|
|
Less |
INTEREST (D) |
96.716 |
99.039 |
42.500 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
310.147 |
93.963 |
102.508 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
216.238 |
179.012 |
108.182 |
|
|
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE
TAX (E-F) (G) |
93.909 |
(85.049) |
(5.674) |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX (G-H) (I) |
93.909 |
(85.049) |
(5.674) |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
1307.545 |
1315.955 |
793.069 |
|
|
|
|
|
|
|
|
|
|
Earnings/ (Loss)
Per Share (Rs.) |
9390.90 |
(8504.90) |
(567.40) |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
PAT / Total Income |
(%) |
2.16
|
(2.55)
|
(0.20)
|
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
1.52
|
(1.59)
|
(0.11)
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.08
|
(0.12)
|
(0.01)
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
5.87
|
9.14
|
7.66
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.19
|
3.38
|
2.84
|
LOCAL AGENCY FURTHER INFORMATION
|
Check
List by Info Agents |
Available in Report
(Yes / No) |
|
1) Year of Establishment |
Yes |
|
2) Locality of the firm |
Yes |
|
3) Constitutions of the firm |
Yes |
|
4) Premises details |
No |
|
5) Type of Business |
Yes |
|
6) Line of Business |
Yes |
|
7) Promoter’s background |
Yes |
|
8) No. of employees |
Yes |
|
9) Name of person contacted |
No |
|
10) Designation of contact person |
No |
|
11) Turnover of firm for last three years |
Yes |
|
12) Profitability for last three years |
Yes |
|
13) Reasons for variation <> 20% |
-- |
|
14) Estimation for coming financial year |
No |
|
15) Capital in the business |
Yes |
|
16) Details of sister concerns |
Yes |
|
17) Major suppliers |
No |
|
18) Major customers |
No |
|
19) Payments terms |
No |
|
20) Export / Import details (if
applicable) |
No |
|
21) Market information |
-- |
|
22) Litigations that the firm / promoter
involved in |
-- |
|
23) Banking Details |
Yes |
|
24) Banking facility details |
Yes |
|
25) Conduct of the banking account |
-- |
|
26) Buyer visit details |
-- |
|
27) Financials, if provided |
Yes |
|
28) Incorporation details, if applicable |
Yes |
|
29) Last accounts filed at ROC |
Yes |
|
30) Major Shareholders, if available |
Yes |
|
31)
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32)
PAN of Proprietor/Partner/Director, if available |
Yes |
|
33)
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34)
External Agency Rating, if available |
Yes |
UNSECURED LOANS
|
Particulars |
31.03.2013 (Rs.
in Millions) |
31.03.2012 (Rs.
in Millions) |
|
LONG-TERM BORROWINGS |
|
|
|
Rupee term loans from others |
2.059 |
2.059 |
|
Inter corporate borrowings |
5528.169 |
5585.269 |
|
|
|
|
|
LONG-TERM BORROWINGS |
|
|
|
Working Capital Loans From Banks (Unsecured) |
805.879 |
0.000 |
|
Total
|
6336.107 |
5587.328 |
Loans from
Department of Biotechnology (DBT)
Term Loans from Department
of Biotechnology (DBT) are payable in ten equal annual installments and will
commence after six months of the scheduled completion of the project.
(A)Zero Coupon
Optionally Convertible Loan from bodies corporate are convertible into equity
shares of the Company at fair value to be determined at the time of conversion
and if not opted for conversion ,shall be repayable on completion of 20 years
from the date of first disbursement or such period as maybe mutually agreed.
Note:
The registered office of the company has been shifted from 2nd Floor, Chitrakoot, shree Ram
Mills Premises, Ganpatrao Kadam Marg, Worli, Mumbai – 400 013, Maharashtra,
India to the present address w.e.f. 05.04.2007.
OPERATIONAL AND
FINANCIAL REVIEW:
During the year,
total revenue from sales and services were at Rs. 4334.700 Millions as compared
to Rs.3338.100 Millions for 2011-12.
Export earnings
for the year were recorded at Rs. 1707.000 Millions as against Rs. 1263.900 Millions
for 2011-12. During the year, Company has launched multiple products in
different therapy areas. Pedialb TM – Human Norma lAlbumin 5% solution,
recommended in children for indications like hypovolaemic shock,
hypoproteinemia and burns. Relist at TM –Hemostatic kit containing human
thrombin, indicated as a haemostatic device for surgical procedures.In the
international markets, Company has made further progress in terms of product
registrations (recombinant biosimilars).
VIEW INDEX OF
CHARGES
|
S.No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount
secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
10474311 |
30/01/2014 |
1,000,000,000.00 |
Axis Bank
Limited |
AXIS HOUSE, GROUND
FLOOR,, WADIA INTERNATIONAL CE |
B94977089 |
|
2 |
10258255 |
19/11/2010 |
12,650,000.00 |
Department of
Biotechnology |
Block 2, CGO
Complex, Lodhi Road,, New Delhi, Del |
B00571265 |
|
3 |
10257683 |
19/11/2010 |
3,900,000.00 |
Department of
Biotechnology |
Block 2, CGO
Complex, Lodhi Road,, New Delhi, Del |
B00498733 |
|
4 |
10115694 |
10/09/2013 * |
1,850,000,000.00 |
Canara Bank |
Prime Corporate Branch-II,2nd
Floor,, Varma Chamb |
B86067923 |
*
Date of charge modification
FIXED
ASSETS:
Tangible
assets
- Leasehold land
- Buildings
- Plant and machinery
- Data processing equipment
- Vehicles
- Furniture and fixture
Intangible
assets
- Patents, trade
- Marks, designs, etc
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or anti-terrorism
sanction laws or whose assets were seized, blocked, frozen or ordered forfeited
for violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.47 |
|
|
1 |
Rs.102.95 |
|
Euro |
1 |
Rs.84.60 |
INFORMATION DETAILS
|
Report Prepared
by : |
SNT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
7 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
62 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.